Radiation treatment for vulvar cancer that is new or has returned
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a new type of radiation placed directly into the tumor to treat vulvar cancer that is new or has come back. It may be an option for people who cannot have surgery or who have limited treatment choices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have vulvar cancer that is newly diagnosed or has come back in the same area.
- The tumor is 7 centimeters or smaller (about the size of a small apple).
- You are age 18 or older.
- You are generally able to care for yourself (ECOG score 3 or less).
- Your doctor agrees that placing radiation sources into the tumor is a good option for you.
- You have not had chemotherapy or immunotherapy in the past 4 weeks and are not taking medications that suppress your immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment that places tiny radiation “seeds” inside/near the chest tumor to treat recurrent lung cancer. It may help people whose cancer has come back and can be safely reached by the radiation device.
This trial tests a new type of radiation using tiny alpha-emitting seeds placed directly into the tumor. It is for people whose prostate cancer came back in the gland after initial treatment but hasn't spread elsewhere.
This trial tests a special radiation device (DaRT) placed directly into skin cancer tumors. It is designed for patients with weakened immune systems (immunocompromised) who have a single skin cancer lesion on the skin (not spread elsewhere).
This trial tests a new type of radiation implant placed directly into the prostate to treat cancer that has come back after initial treatment. It may offer a targeted option for people whose cancer is only in the prostate area.
This trial tests a radiation-emitting device placed near the tumor to treat certain malignant skin cancers that can be fully covered. It may help shrink or control the cancer at the skin site where the device is applied.
This trial tests a new type of radiation therapy (DaRT) that uses tiny, implantable seeds to deliver targeted alpha radiation to breast tumors. It is designed for older patients (65+) or those who are too frail for surgery, offering a less invasive option for controlling the cancer.
Hear when a new Carcinoma of the Vulva trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.